{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 4-Amino-3-(4-methylphenyl)butanoic acid
| image = Tolibut.svg
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 28311-38-8
| CAS_supplemental = <br />28311-37-7 ([[hydrochloride|HCl]])
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 49344
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 44852

<!--Chemical data-->
| C=11 | H=15 | N=1 | O=2
| molecular_weight = 193.2423 g/mol
| smiles = CC1=CC=C(C=C1)C(CC(=O)O)CN
| StdInChI_Ref = 
| StdInChI = 1S/C11H15NO2/c1-8-2-4-9(5-3-8)10(7-12)6-11(13)14/h2-5,10H,6-7,12H2,1H3,(H,13,14)
| StdInChIKey_Ref = 
| StdInChIKey = MSZRPURXKHMSFF-UHFFFAOYSA-N
| synonyms = 
}}

'''Tolibut''', also known as '''3-(''p''-tolyl)-4-aminobutyric acid''' (or '''β-(4-methylphenyl)-GABA'''), is [[drug]] that was developed in [[Russia]]. It is an [[structural analog|analogue]] of [[γ-aminobutyric acid]] (GABA) (that is, a [[GABA analogue]]) and is the 4-methyl analogue of [[phenibut]], and is also an analogue of [[baclofen]] where the 4-chloro substitution has been replaced with a 4-methyl substition. Tolibut has been described as possessing [[analgesic]], [[tranquilizer|tranquilizing]], and [[neuroprotective]] properties. It is not fully clear as to whether the drug was ever approved or used medically in Russia, though it may have been.<ref name="TyurenkovBorodkina2012">{{cite journal|last1=Tyurenkov|first1=I. N.|last2=Borodkina|first2=L. E.|last3=Bagmetova|first3=V. V.|title=Functional Aspects of Neuroprotective Effects of New Salts and Compositions of Baclofen in the Convulsive Syndrome Caused by Electroshock|journal=Bulletin of Experimental Biology and Medicine|volume=153|issue=5|year=2012|pages=710–713|issn=0007-4888|doi=10.1007/s10517-012-1806-5}}</ref><ref name="Morozov1977">{{cite journal|title=Effect of analogs of γ -aminobutyric acid on the uptake of [3H]-γ -aminobutyric acid by synaptosomes of the rat brain|authors=I. S. Morozov, G. I. Kovalev, N. I. Maisov, G. V. Kovalev, K. S. Raevskii|date=January 1977|volume=11|issue=1|pages=10-12|doi=10.1007/BF00779108|url=https://link.springer.com/article/10.1007/BF00779108}}</ref><ref name="pmid3556547">{{cite journal | vauthors = Dmitriev AV, ((Andreev NIu)) | title = [The spectrum of analgesic activity of baclofen and tolibut] | language = Russian | journal = Farmakol Toksikol | volume = 50 | issue = 1 | pages = 24–7 | year = 1987 | pmid = 3556547 | doi = | url = }}</ref><ref name="pmid1363942">{{cite journal | vauthors = ((Artem'ev IIu)), ((Darinskiĭ IuA)), Sologub MI | title = [A hypothesis of the possible mechanism of the action of analgesic agents at the neuronal level] | language = Russian | journal = Eksp Klin Farmakol | volume = 55 | issue = 1 | pages = 16–8 | year = 1992 | pmid = 1363942 | doi = | url = }}</ref> Tolibut probably acts as a [[GABAB receptor|GABA<sub>B</sub> receptor]] [[agonist]] similarly to phenibut and baclofen.{{Citation needed|date=March 2016}}

==See also==
* [[4-Fluorophenibut]]

==References==
{{Reflist|2}}

{{Anxiolytics}}
{{Sedatives}}
{{GABA receptor modulators}}

[[Category:Abandoned drugs]]
[[Category:Analgesics]]
[[Category:Anxiolytics]]
[[Category:GABA analogues]]
[[Category:Neuroprotective agents]]
[[Category:Russian drugs]]

{{Nervous-system-drug-stub}}